Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Neurologica Belgica|June 3, 2010
Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosisS Peric', V Rakocevic-Stojanovic, Z Stevic, et al.Clinical Neurology and Neurosurgery|September 13, 2014
Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1V Rakocevic-Stojanovic, S Peric, R Madzarevic, et al.Acta Neurologica Scandinavica|June 30, 2017
Prospective measurement of quality of life in myotonic dystrophy type 1S Peric, C Heatwole, E Durovic, et al.Clinical Neurology and Neurosurgery|July 10, 2012
The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravisA Nikolic, P Djukic, I Basta, et al.Journal of Neurology|July 4, 2018
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisoloneG G A van Lieverloo, S Peric, P E Doneddu, et al.Journal of Autoimmunity|December 31, 2013
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravisP Zisimopoulou, P Evangelakou, J Tzartos, et al.Journal of Neuroimmunology|May 31, 2015
MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational studyA I Tsonis, P Zisimopoulou, K Lazaridis, et al.Journal of Neuroimmunology|March 6, 2016
Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigenC Stergiou, K Lazaridis, V Zouvelou, et al.Pageof 2